PPARG and cancer: On the other hand, antiproliferative effects of TZDs on breast, prostate, and other types of cancer, have been evidenced in malignant human cell lines and rodents [327,331,332], together with the results that combination with PPARγ agonists may improve some cancer therapies [327].